1. Home
  2. ATKR vs MLYS Comparison

ATKR vs MLYS Comparison

Compare ATKR & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atkore Inc.

ATKR

Atkore Inc.

N/A

Current Price

$59.44

Market Cap

2.3B

Sector

Miscellaneous

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$26.74

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATKR
MLYS
Founded
1959
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
ATKR
MLYS
Price
$59.44
$26.74
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$75.67
$47.33
AVG Volume (30 Days)
224.4K
975.3K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
2.15%
N/A
EPS Growth
N/A
N/A
EPS
0.44
N/A
Revenue
$2,850,378,000.00
N/A
Revenue This Year
$6.86
N/A
Revenue Next Year
$3.94
N/A
P/E Ratio
$139.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.92
$10.44
52 Week High
$80.06
$47.65

Technical Indicators

Market Signals
Indicator
ATKR
MLYS
Relative Strength Index (RSI) 30.48 35.82
Support Level $58.75 $12.98
Resistance Level $60.48 $30.05
Average True Range (ATR) 1.74 1.47
MACD -0.55 -0.03
Stochastic Oscillator 7.86 25.68

Price Performance

Historical Comparison
ATKR
MLYS

About ATKR Atkore Inc.

Atkore Inc is a manufacturer of Electrical products for the non-residential construction and renovation markets, as well as residential markets, and Safety & Infrastructure products for the construction and industrial markets. The Electrical segment manufactures products used in the construction of electrical power systems including conduit, cable, and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The Safety & Infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security, and cable management. These solutions are marketed to contractors, original equipment manufacturers (OEMs), and end-users. The majority of revenue is generated from the Electrical segment.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: